Skip to main content
. 2015 Mar 9;10:9. doi: 10.1186/s13027-015-0004-2

Table 2.

Effects of Loco-regional treatment on tumor growth in mouse models of hepatocellular carcinoma

Study model Treatment Effects on tumor Reference
HepG2/ADM human hepatoma mouse model nHAPs, rmhTNF-alpha, ADM, mitomycin, 5-FU Tumor growth reduction [52]
GPC3-negative colorectal adenocarcinoma mouse model Glypican-3, RFA Tumor growth reduction [53,54]
HCCLM3 mouse model nsPEF Tumor growth reduction
Hep3B xenograft mouse model 5 Gold nanoparticles, RF Tumor growth reduction [56]